Debt-to-equity of Surface Oncology, Inc. from 30 Sep 2018 to 30 Jun 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Surface Oncology, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Jun 2023.
  • Surface Oncology, Inc. Debt-to-equity for the quarter ending 30 Jun 2023 was 64%, a 25% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Surface Oncology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2023 64% +13% +25% 30 Jun 2023
Q1 2023 65% +18% +37% 31 Mar 2023
Q4 2022 57% +14% +32% 31 Dec 2022
Q3 2022 55% +16% +42% 30 Sep 2022
Q2 2022 51% +8.9% +21% 30 Jun 2022
Q1 2022 47% +0.58% +1.2% 31 Mar 2022
Q4 2021 44% -10% -19% 31 Dec 2021
Q3 2021 39% -36% -48% 30 Sep 2021
Q2 2021 42% -40% -49% 30 Jun 2021
Q1 2021 47% -44% -49% 31 Mar 2021
Q4 2020 54% -38% -42% 31 Dec 2020
Q3 2020 75% -4.5% -5.7% 30 Sep 2020
Q2 2020 82% +8.3% +11% 30 Jun 2020
Q1 2020 91% +21% +30% 31 Mar 2020
Q4 2019 92% -9.9% -9.7% 31 Dec 2019
Q3 2019 79% -168% -68% 30 Sep 2019
Q2 2019 74% 30 Jun 2019
Q1 2019 70% 31 Mar 2019
Q4 2018 102% 31 Dec 2018
Q3 2018 247% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.